Prevail Partners
North America, Pennsylvania, United States, Philadelphia
Description
Prevail Partners is an investment fund focused on life sciences companies.
Investor Profile
Prevail Partners has backed more than 6 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 83% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Canada.
- Strong thematic focus on Health Care, Pharmaceutical, Biotechnology.
- Led 1 rounds in the past year.
Stage Focus
- Post Ipo Equity (33%)
- Series A (33%)
- Series Unknown (17%)
- Seed (17%)
Country Focus
- United States (50%)
- United Kingdom (33%)
- Canada (17%)
Industry Focus
- Health Care
- Pharmaceutical
- Biotechnology
- Medical Device
- Medical
- Oncology
- Therapeutics
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.